President Trump signed an executive order designed to increase U.S. capacity to manufacture drugs domestically.

President Donald Trump signed an executive order to encourage domestic prescription drug manufacturing and cut down on the time it takes to approve U.S. pharmaceutical plants.

President Donald Trump signed an executive order to incentivize drug manufacturing in the U.S. The order comes ahead of Trump's planned tariffs on pharmaceuticals imported into the U.S. U.S. production in the pharmaceutical industry has shrunk significantly in recent decades due to lower costs for labor and other parts of the process in countries like China and some European nations.